Literature DB >> 12435108

Coreceptor usage and biological phenotypes of HIV-1 isolates.

Tonie Cilliers1, Lynn Morris.   

Abstract

The discovery of chemokine receptors as HIV-1 entry molecules or "coreceptors" has lead to a greater understanding of how HIV-1 infects human cells. This has provided insight into the biological properties of HIV-1 isolates and unravelled the meaning of the syncytium-inducing and non-syncytium-inducing phenotypes. Understanding how HIV-1 exploits these coreceptors has given way to novel approaches to controlling HIV. As a result a new class of drugs has emerged that are being tested to prevent virus infection and to act as an alternative, or adjunct, to existing anti-retroviral drugs for HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435108     DOI: 10.1515/CCLM.2002.160

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

Review 1.  Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.

Authors:  Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

2.  Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage.

Authors:  Immaculate L Nankya; Denis M Tebit; Awet Abraha; Fred Kyeyune; Richard Gibson; Oyebisi Jegede; Gabrielle Nickel; Eric J Arts
Journal:  AIDS Res Ther       Date:  2015-10-03       Impact factor: 2.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.